Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease

MLA

Valter Donadon, et al. “Metformin and Reduced Risk of Hepatocellular Carcinoma in Diabetic Patients with Chronic Liver Disease.” Liver International : Official Journal of the International Association for the Study of the Liver, vol. 30, no. 5, Mar. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a658f30fea00e5898658a7c5cde40dc&authtype=sso&custid=ns315887.

APA

Valter Donadon, Giorgio Zanette, Maria Dal Mas, Pietro Casarin, & Massimiliano Balbi. (2010). Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver International : Official Journal of the International Association for the Study of the Liver, 30(5).

Chicago

Valter Donadon, Giorgio Zanette, Maria Dal Mas, Pietro Casarin, and Massimiliano Balbi. 2010. “Metformin and Reduced Risk of Hepatocellular Carcinoma in Diabetic Patients with Chronic Liver Disease.” Liver International : Official Journal of the International Association for the Study of the Liver 30 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a658f30fea00e5898658a7c5cde40dc&authtype=sso&custid=ns315887.